Cluster of Escherichia coli Isolates Producing a Plasmid-Mediated OXA-48 β-Lactamase in a Spanish Hospital in 2012

Escherichia colisequence type 131: epidemiology and challenges in treatment

(2014) Zubair A Qureshi et al.   Expert Review of Anti-Infective Therapy

Carbapenemase-Producing Enterobacteriaceae in Spain in 2012

(2013) Jesús Oteo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

“Stormy waters ahead”: global emergence of carbapenemases

(2013) Gopi Patel et al.   Frontiers in Microbiology

Surveillance and Molecular Epidemiology of Klebsiella pneumoniae Isolates That Produce Carbapenemases: First Report of OXA-48-Like Enzymes in North America

(2012) Christine Lascols et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

(2012) R. Cantón et al.   CLINICAL MICROBIOLOGY AND INFECTION

OXA-48-like carbapenemases: the phantom menace

(2012) L. Poirel et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

First Clinical Cases of OXA-48-Producing Carbapenem-Resistant Klebsiella pneumoniae in the United States: the "Menace" Arrives in the New World

(2012) A. J. Mathers et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Carbapenem resistance in Enterobacteriaceae: here is the storm!

(2012) Patrice Nordmann et al.   TRENDS IN MOLECULAR MEDICINE

Genetic Features of the Widespread Plasmid Coding for the Carbapenemase OXA-48

(2011) Laurent Poirel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae

(2010) Caroline Dallenne et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Salmonella enterica serotype Typhimurium carrying hybrid virulence-resistance plasmids (pUO-StVR): A new multidrug-resistant group endemic in Spain

(2007) Ana Herrero et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY